Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

759 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party.
Santoro N, Mooyaart JE, Devillier R, Koc Y, Vydra J, Castagna L, Gülbas Z, Martin JD, Araujo MC, Kulagin A, Arat M, Arroyo CH, Martelli MP, Di Ianni M, Hoogenboom JD, de Wreede LC, Ruggeri A, Chabannon C. Santoro N, et al. Among authors: ruggeri a. Bone Marrow Transplant. 2023 Jan;58(1):54-60. doi: 10.1038/s41409-022-01839-8. Epub 2022 Oct 10. Bone Marrow Transplant. 2023. PMID: 36216975
Incidence and risk factors of EBV reactivation after unrelated cord blood transplantation: a Eurocord and Société Française de Greffe de Moelle-Therapie Cellulaire collaborative study.
Dumas PY, Ruggeri A, Robin M, Crotta A, Abraham J, Forcade E, Bay JO, Michallet M, Bertrand Y, Socié G, Ionescu I, Gluckman E, Milpied N, Rocha V. Dumas PY, et al. Among authors: ruggeri a. Bone Marrow Transplant. 2013 Feb;48(2):253-6. doi: 10.1038/bmt.2012.117. Epub 2012 Jul 9. Bone Marrow Transplant. 2013. PMID: 22773124
Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Tucunduva L, Ruggeri A, Sanz G, Furst S, Socié G, Michallet M, Arcese W, Milpied N, Yakoub-Agha I, Linkesch W, Cornelissen J, Mannone L, Iori AP, Ribera JM, Sanz J, Montesinos P, Purtill D, Labopin M, Gluckman E, Mohty M, Rocha V. Tucunduva L, et al. Among authors: ruggeri a. Bone Marrow Transplant. 2014 Jul;49(7):887-94. doi: 10.1038/bmt.2014.72. Bone Marrow Transplant. 2014. PMID: 24986801
Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia.
Ruggeri A, Labopin M, Sanz G, Piemontese S, Arcese W, Bacigalupo A, Blaise D, Bosi A, Huang H, Karakasis D, Koc Y, Michallet M, Picardi A, Sanz J, Santarone S, Sengelov H, Sierra J, Vincent L, Volt F, Nagler A, Gluckman E, Ciceri F, Rocha V, Mohty M; Eurocord, Cord Blood Committee of Cellular Therapy and Immunobiology working party-EBMT; ALWP-EBMT study. Ruggeri A, et al. Leukemia. 2015 Sep;29(9):1891-900. doi: 10.1038/leu.2015.98. Epub 2015 Apr 17. Leukemia. 2015. PMID: 25882700
Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMT.
Battipaglia G, Labopin M, Candoni A, Fanin R, El Cheikh J, Blaise D, Michallet M, Ruggeri A, Contentin N, Ribera JM, Stadler M, Sierra J, von dem Borne PA, Bloor A, Socié G, Nagler A, Mohty M. Battipaglia G, et al. Among authors: ruggeri a. Bone Marrow Transplant. 2017 Apr;52(4):592-599. doi: 10.1038/bmt.2016.302. Epub 2017 Jan 16. Bone Marrow Transplant. 2017. PMID: 28092357
Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT.
Ruggeri A, Labopin M, Bacigalupo A, Afanasyev B, Cornelissen JJ, Elmaagacli A, Itälä-Remes M, Blaise D, Meijer E, Koc Y, Milpied N, Schouten HC, Kroeger N, Mohty M, Nagler A. Ruggeri A, et al. J Hematol Oncol. 2018 Mar 15;11(1):40. doi: 10.1186/s13045-018-0586-4. J Hematol Oncol. 2018. PMID: 29544522 Free PMC article.
Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia 45 years of age and over.
Santoro N, Labopin M, Ciceri F, Van Lint MT, Nasso D, Blaise D, Arcese W, Tischer J, Bruno B, Ehninger G, Koc Y, Santarone S, Huang XJ, Savani BN, Mohty M, Ruggeri A, Nagler A. Santoro N, et al. Among authors: ruggeri a. Cancer. 2019 May 1;125(9):1499-1506. doi: 10.1002/cncr.31941. Epub 2019 Jan 8. Cancer. 2019. PMID: 30620383 Free article.
Measurable residual disease (MRD) testing for acute leukemia in EBMT transplant centers: a survey on behalf of the ALWP of the EBMT.
Nagler A, Baron F, Labopin M, Polge E, Esteve J, Bazarbachi A, Brissot E, Bug G, Ciceri F, Giebel S, Gilleece MH, Gorin NC, Lanza F, Peric Z, Ruggeri A, Sanz J, Savani BN, Schmid C, Shouval R, Spyridonidis A, Versluis J, Mohty M. Nagler A, et al. Among authors: ruggeri a. Bone Marrow Transplant. 2021 Jan;56(1):218-224. doi: 10.1038/s41409-020-01005-y. Epub 2020 Jul 28. Bone Marrow Transplant. 2021. PMID: 32724200 Free article.
Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Battipaglia G, Labopin M, Hamladji RM, Blaise D, Chevallier P, Brissot E, Gerbitz A, Socié G, Afanasyev B, Ciceri F, Meijer E, Koc Y, Cornelissen JJ, Huynh A, Ozdogu H, Maertens J, Paul F, Labussière-Wallet H, Ruggeri A, Aljurf M, Bazarbachi A, Savani B, Nagler A, Mohty M. Battipaglia G, et al. Among authors: ruggeri a. Cancer. 2021 Jan 15;127(2):209-218. doi: 10.1002/cncr.33255. Epub 2020 Oct 29. Cancer. 2021. PMID: 33119152 Free article.
759 results